Aivita presents phase II data for its personalized GBM vaccine candidate, AV-GBM-1 June 9, 2021 No Comments
First-in-human study shows anti-ICOS KY-1044 well tolerated alone and with atezolizumab June 9, 2021 No Comments
China's NMPA approves clinical trial application for second indication of CT-120 June 8, 2021 No Comments
StemVacs-V iPSC amplifies cancer-specific immune response and shows synergy with other therapies June 8, 2021 No Comments
Responses seen with BDB-001 plus pembrolizumab in patients with advanced solid tumors June 8, 2021 No Comments
Phase I trial evaluates GNC-039 in relapsed/refractory or metastatic solid tumors June 8, 2021 No Comments
RSS